Computational Intelligence In Oncology

Computational Intelligence in Cancer Diagnosis: Progress and Challenges provides insights into the current strength and weaknesses of different applications and research findings on computational intelligence in cancer research. The book improves the exchange of ideas and coherence among various computational intelligence methods and enhances the relevance and exploitation of application areas for both experienced and novice end-users. Topics discussed include neural networks, fuzzy logic, connectionist systems, genetic algorithms, evolutionary computation, cellular automata, self-organizing systems, soft computing, fuzzy systems, and hybrid intelligent systems. The book's chapters are written by international experts from both cancer research, oncology and computational sides to cover different aspects and make it comprehensible for readers with no background on informatics. Contains updated information about advanced computational intelligence, spanning the areas of neural networks, fuzzy logic, connectionist systems, genetic algorithms, evolutionary computation, cellular automata, self-organizing systems, soft computing, fuzzy systems, and hybrid intelligent systems in diagnosing cancer diseases Discusses several cancer types, including their detection, treatment and prevention Presents case studies that illustrate the applications of intelligent computing in data analysis to help readers to analyze and advance their research in cancer

This book encapsulates recent applications of CI methods in the field of computational oncology, especially cancer diagnosis, prognosis, and its optimized therapeutics. The cancer has been known as a heterogeneous disease categorized in several different subtypes. According to WHO’s recent report, cancer is a leading cause of death worldwide, accounting for over 10 million deaths in the year 2020. Therefore, its early diagnosis, prognosis, and classification to a subtype have become necessary as it facilitates the subsequent clinical management and therapeutics plan. Computational intelligence (CI) methods, including artificial neural networks (ANNs), fuzzy logic, evolutionary computations, various machine learning and deep learning, and nature-inspired algorithms, have been widely utilized in various aspects of oncology research, viz. diagnosis, prognosis, therapeutics, and optimized clinical management. Appreciable progress has been made toward the understanding the hallmarks of cancer development, progression, and its effective therapeutics. However, notwithstanding the extrinsic and intrinsic factors which lead to drastic increment in incidence cases, the detection, diagnosis, prognosis, and therapeutics remain an apex challenge for the medical fraternity. With the advent in CI-based approaches, including nature-inspired techniques, and availability of clinical data from various high-throughput experiments, medical consultants, researchers, and oncologists have seen a hope to devise and employ CI in various aspects of oncology. The main aim of the book is to occupy state-of-the-art applications of CI methods which have been derived from core computer sciences to back medical oncology. This edited book covers artificial neural networks, fuzzy logic and fuzzy inference systems, evolutionary algorithms, various nature-inspired algorithms, and hybrid intelligent systems which are widely appreciated for the diagnosis, prognosis, and optimization of therapeutics of various cancers. Besides, this book also covers multi-omics exploration, gene expression analysis, gene signature identification of cancers, genomic characterization of tumors, anti-cancer drug design and discovery, drug response prediction by means of CI, and applications of IoT, IoMT, and blockchain technology in cancer research.

Artificial Intelligence in Cancer: Diagnostic to Tailored Treatment provides theoretical concepts and practical techniques of AI and its applications in cancer management, building a roadmap on how to use AI in cancer at different stages of healthcare. It discusses topics such as the impactful role of AI during diagnosis and how it can support clinicians to make better decisions, AI tools to help pathologists identify exact types of cancer, how AI supports tumor profiling and can assist surgeons, and the gains in precision for oncologists using AI tools. Additionally, it provides information on AI used for survival and remission/recurrence analysis. The book is a valuable source for bioinformaticians, cancer researchers, oncologists, clinicians and members of the biomedical field who want to understand the promising field of AI applications in cancer management. Discusses over 20 real cancer examples, bringing state-of-the-art cancer cases in which AI was used to help the medical personnel Presents over 100 diagrams, making it easier to comprehend AI’s results on a specific problem through visual resources Explains AI algorithms in a friendly manner, thus helping the reader implement or use them in a specific cancer case

This book explores various applications of deep learning to the diagnosis of cancer,while also outlining the future face of deep learning-assisted cancer diagnostics. As is commonly known, artificial intelligence has paved the way for countless new solutions in the field of medicine. In this context, deep learning is a recent and remarkable sub-field, which can effectively cope with huge amounts of data and deliver more accurate results. As a vital research area, medical diagnosis is among those in which deep learning-oriented solutions are often employed. Accordingly, the objective of this book is to highlight recent advanced applications of deep learning for diagnosing different types of cancer. The target audience includes scientists, experts, MSc and PhD students, postdocs, and anyone interested in the subjects discussed. The book can be used as a reference work to support courses on artificial intelligence, medical and biomedicaleducation.

There exists a profound conflict at the heart of oncology drug development. The efficiency of the drug development process is falling, leading to higher costs per approved drug, at the same time personalised medicine is limiting the target market of each new medicine. Even as the global economic burden of cancer increases, the current paradigm in drug development is unsustainable. In this book, we discuss the development of techniques in machine learning for improving the efficiency of oncology drug development and delivering cost-effective precision treatment. We consider how to structure data for drug repurposing and target identification, how to improve clinical trials and how patients may view artificial intelligence.

Computational Intelligence is comparatively a new field but it has made a tremendous progress in virtually every discipline right from engineering, science, business, m- agement, aviation to healthcare. Computational intelligence already has a solid track-record of applications to healthcare, of which this book is a continuation. We would like to refer the reader to the excellent previous volumes in this series on computational intelligence in heal- care [1-3]. This book is aimed at providing the most recent advances and state of the art in the practical applications of computational intelligence paradigms in healthcare. It - cludes nineteen chapters on using various computational intelligence methods in healthcare such as intelligent agents and case-based reasoning. A number of fielded applications and case studies are presented. Highlighted are in particular novel c- putational approaches to the semantic management of health information such as in the Web 2.0, mobile agents such as in portable devices, learning agents capable of adapting to diverse clinical settings through case-based reasoning, and statistical - proaches in computational intelligence. This book is targeted towards scientists, application engineers, professors, health professionals, professors, and students. Background information on computational intelligence has been provided whenever necessary to facilitate the comprehension of a broad audience including healthcare practitioners.

The book collects high-quality original contributions, containing the latest developments or applications of practical use and value, presenting interdisciplinary research and review articles in the field of intelligent systems for computational oncology and neurological disorders

This pioneering book explores how machine learning and other AI techniques impact millions of cancer patients who benefit from ionizing radiation. It features contributions from global researchers and clinicians, focusing on the clinical applications of machine learning for medical physics. AI and machine learning have attracted much recent attention and are being increasingly adopted in medicine, with many clinical components and commercial software including aspects of machine learning integration. General principles and important techniques in machine learning are introduced, followed by discussion of clinical applications, particularly in radiomics, outcome prediction, registration and segmentation, treatment planning, quality assurance, image processing, and clinical decision-making. Finally, a futuristic look at the role of AI in radiation oncology is provided. This book brings medical physicists and radiation oncologists up to date with the most novel applications of machine learning to medical physics. Practitioners will appreciate the insightful discussions and detailed descriptions in each chapter. Its emphasis on clinical applications reaches a wide audience within the medical physics profession.